HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mammary myofibroblastoma with leiomyomatous differentiation.

Abstract
An unusual example of mammary myofibroblastoma in a 36-year-old woman was reported. The central portion resembled mammary myofibroblastoma or solitary fibrous tumor of other sites and showed reactivity for CD34 and muscle-specific actin, with few cells staining for desmin. The peripheral portion resembled leiomyoma and showed strong reactivity for actin and desmin but only focal staining for CD34. We interpret this tumor as mammary myofibroblastoma showing frank peripheral leiomyomatous differentiation. Although closely related to solitary fibrous tumor, mammary myofibroblastoma appears slightly different because of its consistent slant toward myoid differentiation in the form of actin and variable desmin reactivity as opposed to the rare and sparse immunohistochemical expression of myoid features by solitary fibrous tumors of other sites. This case demonstrates this phenomenon carried to an extreme, a feature not previously documented in mammary myofibroblastoma. It is of interest to note the modulation of the antigenic profile with the differentiation process, that is, loss of CD34 and gain of desmin accompanying the myoid differentiation.
AuthorsT M Thomas, A Myint, C K Mak, J K Chan
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 107 Issue 1 Pg. 52-5 (Jan 1997) ISSN: 0002-9173 [Print] England
PMID8980367 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD34
  • Biomarkers, Tumor
  • Cytoskeletal Proteins
  • S100 Proteins
Topics
  • Adult
  • Antigens, CD34 (analysis)
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (chemistry, pathology)
  • Cell Differentiation
  • Cytoskeletal Proteins (analysis)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Leiomyoma (chemistry, pathology)
  • Neoplasms, Muscle Tissue (chemistry, pathology)
  • S100 Proteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: